01/19/22 1:25 AMOTC : RLFTF, RLFTY covid-19Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved TherapiesRELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company, NRxRHEA-AIneutral
01/14/22 1:30 AMOTC : RLFTF, RLFTY Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed LawsuitRELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, commented today on the press release that NRxRHEA-AIneutral
01/12/22 1:20 AMOTC : RLFTF, RLFTY Relief Comments on Lawsuit Filed Against It by NeuroRxRELIEF THERAPEUTICS Holding SA (SIX: RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that its collaboration partnerRHEA-AIneutral
01/06/22 1:20 AMOTC : RLFTF, RLFTY covid-19Relief Reports US Collab. Partner Announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved TherapiesRELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company, NRxRHEA-AIneutral
01/05/22 1:20 AMOTC : RLFTF, RLFTY conferencesRelief Therapeutics to Participate in Virtual Investor Conferences in JanuaryRELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced participation in the followingRHEA-AIneutral
01/04/22 1:30 AMOTC : RLFTF, RLFTY Relief Reports that its U.S. Collaboration Partner has Announced the Filing of a Provisional Patent Application for Stable Compositions of Aviptadil Suitable for Human UseRELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company, NRxRHEA-AIneutral
01/03/22 1:25 AMOTC : RLFTF, RLFTY Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SARELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today gives notice of the Extraordinary GeneralRHEA-AIneutral
12/30/21 1:20 AMOTC : RLFTF, RLFTY covid-19Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved TherapiesRELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company of itsRHEA-AIneutral
12/28/21 1:20 AMOTC : RLFTF, RLFTY Relief Reports Successful Conclusion of Patent Examination Procedure for Patent Application Entitled, 'Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis'RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the Swiss Patent OfficeRHEA-AIneutral
12/16/21 1:20 AMOTC : RLFTF, RLFTY Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange CommissionRELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief"), announced today that it has filed a Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission (" SEC") to register Relief as a reportingRHEA-AIneutral
